For investors seeking momentum, PowerShares FTSE RAFI Emerging Markets ETF (PXH - Free Report) is probably on radar now. The fund just hit a 52-week high, which is up roughly 49.9% from its 52-week low price of $11.75/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
PXH in Focus
The product offers exposure to emerging market stocks picked on the basis of factors including book value, cash flow, sales and dividend. Financials, energy and materials are the top three sectors of the fund each with a double-digit weight each. The fund charges 49 bps in fees (see all broad emerging market ETFs here).
Why the Move?
Emerging market equities are on a tear lately. The commodity market recovery, a subdued greenback, compelling valuation and most importantly a hunt for yield made emerging market equities ETFs like PXH an intriguing pick.
More Gains Ahead?
Currently, PXH has a Zacks ETF Rank #2 (Buy). Moreover, the fund has a positive weighted alpha of 14.16. A positive weighted alpha hints at more gains.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
For investors seeking momentum, PowerShares FTSE RAFI Emerging Markets ETF (PXH - Free Report) is probably on radar now. The fund just hit a 52-week high, which is up roughly 49.9% from its 52-week low price of $11.75/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed:
PXH in Focus
The product offers exposure to emerging market stocks picked on the basis of factors including book value, cash flow, sales and dividend. Financials, energy and materials are the top three sectors of the fund each with a double-digit weight each. The fund charges 49 bps in fees (see all broad emerging market ETFs here).
Why the Move?
Emerging market equities are on a tear lately. The commodity market recovery, a subdued greenback, compelling valuation and most importantly a hunt for yield made emerging market equities ETFs like PXH an intriguing pick.
More Gains Ahead?
Currently, PXH has a Zacks ETF Rank #2 (Buy). Moreover, the fund has a positive weighted alpha of 14.16. A positive weighted alpha hints at more gains.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PXH - FREE